Leia Rispoli, MD
Interventional Pain Medicine · Marina del Rey, CANPI 1679993406
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Nalu Medical, Inc. at 46.4% of the total. 2025 is the largest year on record at $13,226, 2.4 times the $5,608 reported in 2019. Among interventional pain medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 526 payments — averaging $66.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$16K
- Boston Scientific$7K
- Medtronic$4K
- Abbott$2K
- Merz Pharmaceuticals, LLC$1K
- Nevro Corp.$1K
- plus $3K from 22 others
What the payments were for
- Consulting fees$9,78828%
- Speaking & faculty fees$7502%
- Travel & lodging$5,55016%
- Food & beverage$18,85654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 69 | $16,210 |
| Boston Scientific | 207 | $7,312 |
| Medtronic(2 entities) | 73 | $4,390 |
| Abbott | 59 | $2,295 |
| Merz Pharmaceuticals, LLC | 32 | $1,095 |
| Nevro Corp. | 14 | $1,060 |
| Biotronik NRO, Inc. | 16 | $542 |
| Curonix LLC | 11 | $467 |
| AbbVie(2 entities) | 3 | $185 |
| Brixton Biosciences, Inc. | 1 | $158 |
| Globus Medical | 4 | $143 |
| Vertiflex, Inc. | 2 | $122 |
| MML US, Inc. | 5 | $117 |
| Saluda Medical Americas, Inc. | 5 | $114 |
| Relievant Medsystems, Inc. | 4 | $112 |
| Stratus Medical, LLC | 2 | $112 |
| Vertex | 4 | $106 |
| SPR Therapeutics, Inc | 1 | $66 |
| Merz North America, Inc. | 2 | $65 |
| Ipsen Biopharmaceuticals, Inc | 2 | $57 |
| Pfizer | 2 | $45 |
| Lundbeck LLC | 2 | $35 |
| Vertos Medical, Inc. | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| IBSA Pharma Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$14,525
- INTELLIS$1,489
- SPECTRA WAVEWRITER$1,150
- Senza Spinal Cord Stimulation System$762
- GENERAL PAIN MANAGEMENT$718
- ADAPTIVESTIM$565
- INTELLIS ADAPTIVESTIM$407
- Proclaim Family of SCS IPGs$369
- Proclaim IPG$350
- WaveWriter Alpha Prime 16$263
- PROCLAIM$254
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$244
- Neural Ice$158
- BOTOX$127
- Prospera$118
- VANTA ADAPTIVESTIM$116
- Superion ISS$115
How this compares
$34,944 in reported general payments places this provider in the 90th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 103 | $1,308 |
| Duloxetine Hcl | 34 | $713 |
| Celecoxib | 19 | $599 |
| Pregabalin | 27 | $257 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $228 |
| Diclofenac Sodium | 15 | $217 |
| Tramadol Hcl | 41 | $137 |
| Methylprednisolone | 17 | $136 |
| Tizanidine Hcl | 18 | $135 |
| Cyclobenzaprine Hcl | 11 | $110 |
| Meloxicam | 32 | $83 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Marina del Rey
- Akash BajajMarina del Rey$14K
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.